Acadia Pharmaceuticals (ACAD) Shares Issued: 2009-2025
Historic Shares Issued for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to $9.4 million.
- Acadia Pharmaceuticals' Shares Issued rose 3416.04% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 million, marking a year-over-year increase of 183.08%. This contributed to the annual value of $6.8 million for FY2024, which is 72.76% down from last year.
- Acadia Pharmaceuticals' Shares Issued amounted to $9.4 million in Q3 2025, which was down 40.94% from $16.0 million recorded in Q2 2025.
- In the past 5 years, Acadia Pharmaceuticals' Shares Issued registered a high of $16.0 million during Q2 2025, and its lowest value of $268,000 during Q3 2024.
- For the 3-year period, Acadia Pharmaceuticals' Shares Issued averaged around $5.4 million, with its median value being $3.6 million (2024).
- Its Shares Issued has fluctuated over the past 5 years, first spiked by 4,342.86% in 2023, then tumbled by 97.90% in 2024.
- Quarterly analysis of 5 years shows Acadia Pharmaceuticals' Shares Issued stood at $4.4 million in 2021, then plummeted by 63.02% to $1.6 million in 2022, then spiked by 236.68% to $5.4 million in 2023, then tumbled by 63.77% to $2.0 million in 2024, then soared by 3,416.04% to $9.4 million in 2025.
- Its Shares Issued was $9.4 million in Q3 2025, compared to $16.0 million in Q2 2025 and $1.8 million in Q1 2025.